Výsledky vyhledávání - Siddhartha Goutam

  • Zobrazuji výsledky 1 - 5 z 5
Upřesnit hledání
  1. 1
    Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells

    Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells Autor Nicholas Jette, Suraj Radhamani, Greydon Arthur, Ruiqiong Ye, Siddhartha Goutam, Anthony Bolyos, Lars F. Petersen, Pinaki Bose, D. Gwyn Bebb, Susan P. Lees‐Miller

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    ATM-Deficient Cancers Provide New Opportunities for Precision Oncology

    ATM-Deficient Cancers Provide New Opportunities for Precision Oncology Autor Nicholas Jette, Mehul Kumar, Suraj Radhamani, Greydon Arthur, Siddhartha Goutam, Steven Yip, Michael Paul Kolinsky, Gareth J. Williams, Pinaki Bose, Susan P. Lees‐Miller

    Vydáno 2020
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy

    Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Im... Autor Alexander Watson, Siddhartha Goutam, Igor Stukalin, Benjamin W. Ewanchuk, Michael Sander, Daniel E. Meyers, Aliyah Pabani, Winson Y. Cheung, Daniel Y.C. Heng, Tina Cheng, Jose Gerard Monzon, Vishal Navani

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Impact of Performance Status on Survival Outcomes and Health Care Utilization in Patients With Advanced NSCLC Treated With Immune Checkpoint Inhibitors

    Impact of Performance Status on Survival Outcomes and Health Care Utilization in Patients With Advanced NSCLC Treated With Immune Checkpoint Inhibitors Autor Daniel E. Meyers, Meghann Pasternak, Samantha Dolter, Heidi A.I. Grosjean, Chloe Lim, Igor Stukalin, Siddhartha Goutam, Vishal Navani, Daniel Yick Chin Heng, Winson Y. Cheung, Don Morris, Aliyah Pabani

    Vydáno 2023
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials

    Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials Autor Chun Loo Gan, Igor Stukalin, Daniel E. Meyers, Shaan Dudani, Heidi A.I. Grosjean, Samantha Dolter, Benjamin W. Ewanchuk, Siddhartha Goutam, Michael Sander, J. Connor Wells, Aliyah Pabani, Tina Cheng, Jose Gerard Monzon, Don Morris, Naveen S. Basappa, Sumanta K. Pal, Lori Wood, Frede Donskov, Toni K. Choueiri, Daniel Y.C. Heng

    Vydáno 2021
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: